GLH's maintenance contract revenue has been declining since 2009 and the acute sector revenue has been the same. It doesn't seem to have the development capability for complex and interconnected large health care system. Non-acute sector is probably where the growth opportunity lies.
I agree with suhm, the current amortization schedule is not appropriate for software asset and there would probably be a write-off if CHIRON is still staying on the book.
The company was expecting a 10% revenue increase. The optimist inside me wants to believe the 1.5 cps is off the new earning and the FY15 NPAT is going to be comparable to FY14. But given how poorly this is communicated it is probably worse than that.
Ann: SA Health Termination of CHIRON, page-7
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add GLH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.965M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 84000 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 67993 | 2 |
View Market Depth
| Last trade - 16.12pm 21/08/2024 (20 minute delay) ? |
| GLH (ASX) Chart |
Day chart unavailable